Category: FDA & Regulatory Policy (Page 6)

July 10, 2015

Alliance Applauds Passage of 21st Century Cures Act in House

The Alliance for Aging Research has issued the following statement on the passage of the 21st Century Cures Act, or H.R. 6, today in the U.S. House of Representatives.
June 30, 2015

Expert Robert Fielding on the Latest in Sarcopenia Research

To help you learn more about what's been going on in the sarcopenia research space, we are linking you to an interview with Roger A. Fielding, Ph.D.
June 12, 2015

The 21st Century Cures Act: A Critical Bill to Improve the Future of Medical Research in America

The 21st Century Cures Act represents a positive change in how American biomedical research will be conducted and streamlines the processes intended to deliver new medical cures and treatment to patients.
May 18, 2015

Letter to DeGette and Upton on 21st Century Cures Bill

This letter is from the Alliance to Rep. Fred Upton and Rep. Diana DeGette applauding their work around the 21st Century Cures bill.
May 15, 2015

ACT-AD Letter to DeGette and Upton Re: 21st Century Cures

This letter is from the ACT-AD Coalition to Rep. Fred Upton and Rep. Diana DeGette applauding their work around the 21st Century Cures bill.
May 11, 2015

Webinar: Targets for the Next Generation of Alzheimer’s Disease Treatment

On April 27 the Alliance's ACT-AD Coalition held a webinar on the future of research, therapeutic development, and treatment of Alzheimer’s disease.
March 10, 2015

Infographic on Pain Incidence and Management

Today we released a survey of 1,600 Americans ages 18 and over that reveals insights on pain and OTC pain medications. This infographic offers a summary of the results.
March 9, 2015

New Survey Shows Americans Prefer Education Over Restricted Access When It Comes to OTC Pain Medications

Results Also Reveal Many Older Adults Use OTC Medications to Relieve Pain
March 4, 2015

Alliance Offers Comment on FDA Testosterone Prescription Labeling Communication

We wanted to share our reaction to communication from the U.S. Food and Drug Administration regarding updates to the labeling of prescription testosterone products.
February 12, 2015

Matching the Needs of Patients with Those of Our Federal Health Agencies

On Tuesday, the Alliance for Aging Research responded to the U.S. House Energy and Commerce Committee 21st Century Cures Initiative and its recently released discussion draft.